Reports


TBIQYR23531-Global Non-small Cell Lung Cancer Therapeutics Market Research Report 2019

  • TBI775313
  • March 18, 2019
  • Global
  • 97 pages
  • QY Market Research
                                              Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.

The global Non-small Cell Lung Cancer Therapeutics market is valued at 6660 million US$ in 2018 is expected to reach 11900 million US$ by the end of 2025, growing at a CAGR of 7.5% during 2019-2025.
This report focuses on Non-small Cell Lung Cancer Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-small Cell Lung Cancer Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GlaxoSmithKline
    Novartis
    AstraZeneca
    Roche
    Bristol-Myers Squibb
    Pfizer
    Eli Lilly
    Sanofi

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Alimta
    Iressa
    Avastin
    Tarceva
    Zykadia
    Tagrisso
    Xalkori
    Cyramza
    Opdivo
    Alecensa

Segment by Application
    Hospital
    Clinic
 

Table of Contents

Executive Summary
1 Non-small Cell Lung Cancer Therapeutics Market Overview
    1.1 Product Overview and Scope of Non-small Cell Lung Cancer Therapeutics
    1.2 Non-small Cell Lung Cancer Therapeutics Segment by Type
        1.2.1 Global Non-small Cell Lung Cancer Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Alimta
        1.2.3 Iressa
        1.2.4 Avastin
        1.2.5 Tarceva
        1.2.6 Zykadia
        1.2.7 Tagrisso
        1.2.8 Xalkori
        1.2.9 Cyramza
        1.2.10 Opdivo
        1.2.11 Alecensa
    1.3 Non-small Cell Lung Cancer Therapeutics Segment by Application
        1.3.1 Non-small Cell Lung Cancer Therapeutics Consumption Comparison by Application (2014-2025)
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Global Non-small Cell Lung Cancer Therapeutics Market by Region
        1.4.1 Global Non-small Cell Lung Cancer Therapeutics Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Non-small Cell Lung Cancer Therapeutics Market Size
        1.5.1 Global Non-small Cell Lung Cancer Therapeutics Revenue (2014-2025)
        1.5.2 Global Non-small Cell Lung Cancer Therapeutics Production (2014-2025)

2 Global Non-small Cell Lung Cancer Therapeutics Market Competition by Manufacturers
    2.1 Global Non-small Cell Lung Cancer Therapeutics Production Market Share by Manufacturers (2014-2019)
    2.2 Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Manufacturers (2014-2019)
    2.3 Global Non-small Cell Lung Cancer Therapeutics Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Non-small Cell Lung Cancer Therapeutics Production Sites, Area Served, Product Types
    2.5 Non-small Cell Lung Cancer Therapeutics Market Competitive Situation and Trends
        2.5.1 Non-small Cell Lung Cancer Therapeutics Market Concentration Rate
        2.5.2 Non-small Cell Lung Cancer Therapeutics Market Share of Top 3 and Top 5 Manufacturers
    ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form